|
Volumn 52, Issue 1 SUPPL., 2007, Pages
|
Clinical Safety Profile of Posterior Juxtascleral Depot Administration of Anecortave Acetate 15 mg Suspension as Primary Therapy or Adjunctive Therapy with Photodynamic Therapy for Treatment of Wet Age-Related Macular Degeneration
a b c d e a |
Author keywords
AMD; anecortave acetate; posterior juxtascleral depot administration; safety
|
Indexed keywords
ANECORTAVE;
PLACEBO;
ABNORMAL VISION;
ACCIDENTAL INJURY;
ADJUVANT THERAPY;
ALOPECIA;
ANISOCORIA;
ARTHRITIS;
ARTICLE;
BLURRED VISION;
CATARACT;
CLINICAL TRIAL;
CONJUNCTIVAL HYPEREMIA;
DEPRESSION;
DIABETES MELLITUS;
DIGESTIVE SYSTEM INJURY;
DISEASE SEVERITY;
DRUG DELIVERY SYSTEM;
DRUG FORMULATION;
DRUG MONITORING;
DRUG SAFETY;
DRUG TOLERABILITY;
EYE DISCOMFORT;
EYE EDEMA;
EYE EXAMINATION;
EYE PAIN;
EYELID EDEMA;
EYELID PRURITUS;
GASTROINTESTINAL DISEASE;
HEALTH CARE ORGANIZATION;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERLIPIDEMIA;
HYPERTENSION;
INFECTION;
INTRAOCULAR FOREIGN BODY;
INTRAOCULAR HYPERTENSION;
INTRAOCULAR PRESSURE;
LACRIMATION;
LUNG DISEASE;
META ANALYSIS;
NAUSEA;
PATIENT COMPLIANCE;
PHOTODYNAMIC THERAPY;
PHYSICAL EXAMINATION;
PIGMENT DISORDER;
PIGMENTATION;
POPULATION RESEARCH;
PRIORITY JOURNAL;
PTOSIS;
PUPIL DISEASE;
RETINA ARTERY OCCLUSION;
RETINA DETACHMENT;
RETINA DISEASE;
RETINA MACULA AGE RELATED DEGENERATION;
RETINOPATHY;
SCAR;
SIDE EFFECT;
SINGLE DRUG DOSE;
SUSPENSION;
SYSTEMATIC REVIEW;
TREATMENT INDICATION;
TREATMENT OUTCOME;
VISUAL ACUITY;
VITREOUS BODY DETACHMENT;
ANGIOGENESIS INHIBITORS;
CLINICAL TRIALS;
DRUG EVALUATION;
DRUG THERAPY, COMBINATION;
HUMANS;
MACULAR DEGENERATION;
PHOTOCHEMOTHERAPY;
PREGNADIENEDIOLS;
SCLERA;
SUSPENSIONS;
|
EID: 33846241094
PISSN: 00396257
EISSN: None
Source Type: Journal
DOI: 10.1016/j.survophthal.2006.11.001 Document Type: Article |
Times cited : (12)
|
References (10)
|